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Detailed information about the replication cycle of viruses and their interactions with host
organisms is required to develop strategies to stop them. Cell biology studies, live-cell
imaging, and systems biology have started to illuminate the multiple and subtly different
pathways that animal viruses use to enter host cells. These insights are revolutionizing
our understanding of endocytosis and the movement of vesicles within cells. In addition,
such insights reveal new targets for attacking viruses before they can usurp the host-cell
machinery for replication.Introduction
Viruses are obligatory intracellular parasites; therefore,
their replication (and the pathogenic consequences of in-
fection) depends critically on the ability to transmit their
genomes from infected to noninfected host organisms
and from infected to uninfected cells. The small size,
structural simplicity, and lack of any metabolic or motile
activities severely limit the types of processes that virus
particles can themselves undertake to promote the trans-
fer process. As passive, inert particles, they have evolved
to exploit the behavior and the physiology of their hosts.
At the cell level, this is manifested in the activation of en-
dogenous cellular responses that provide assistance to
viruses so that they can cross membranes and other bar-
riers and deliver their genes into the cytosol or the nucleus.
Recent studies indicate that cells offer a variety of endocy-
tosis, trafficking, and sorting mechanisms that animal vi-
ruses can take. Moreover, viruses have become valuable
tools to study some of these processes. Here, we review
the general concepts in virus entry and discuss some of
the emerging issues.
Virus Particles as Devices for Targeted
Gene Transfer
A viral particle is composed of nucleic acids (RNA or DNA),
protein, and, in the case of enveloped viruses, membrane
lipids. The proteins include structural components, such
as capsid proteins; matrix proteins; membrane glycopro-
teins; and, in many cases, accessory proteins such as re-
verse transcriptases, RNA polymerases, kinases, and pro-
teases. One or more shells of protein protect the RNA or
DNA genome in the so-called capsid, which is often helical
or icosahedral. Enveloped viruses have, in addition, a lipid
bilayer membrane that serves to protect the capsid and
the genome and operates as a ‘‘transport vesicle’’ during
cell-to-cell transmission.
Transmission involves three main stages: the assembly
of virus particles in infected cells, their release to the extra-
cellular space, and entry into a new cell. NonenvelopedCvirus particles and the capsids of enveloped viruses are
assembled in the cytosol or the nucleus of the infected
cell. The lipid bilayer membrane (envelope) of enveloped
viruses is acquired during a budding process through
a cellular membrane. With few exceptions, the key pro-
teins in the capsid and the envelope are encoded by the
viral genome.
Given that the components of the virus particle are often
synthesized in different parts of the cell, the assembly of
a particle is a remarkable example of coordinated molec-
ular sorting. The assembly processes involve the estab-
lishment of a complex network of specific interactions
that bring the relevant viral components together into
a particle with precise stoichiometry and geometry and
with the exclusion of most cellular components. That all
this is possible with the limited genetic information con-
tained in viral genomes is impressive. It serves as a testa-
ment to the viruses’ ingenious structural designs and the
generous assistance of the cell.
Enveloped particles leave the infected cell inconspicu-
ously by budding and secretion. Nonenveloped viruses
are usually thought to undergo release through cell lysis,
but some may escape by secretory mechanisms after
budding into membrane bound compartments and then
losing their membrane (Altenburg et al., 1980). Others
may subvert cellular autophagy pathways to gain access
to exocytic organelles (Jackson et al., 2005).
The particles released from cells are stable structures
crosslinked by networks of intermolecular interactions.
They are resistant to the stresses encountered in the
extracellular space during transmission from cell to cell
and host to host. However, at the same time, the assembly
and maturation program has made sure that the particles
can fall apart at a moment’s notice during entry into a new
cell. The reversibility of assembly is important to liberate
the genome in infectious form and release the accessory
proteins. Many of the stabilizing interactions in the particle
must be undone: the envelope must be shed, the capsid
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this possible, the entire virus particle or specific proteins in
it are locked in metastable conformations and poised to
undergo major conformational changes when triggered
by appropriate cues during entry (Steven et al., 2005).
The uncoating program is thus built into the virion during
assembly, allowing major transformations in the particle
without the need for external energy.
Like assembly, entry and uncoating typically occur in
several tightly controlled, consecutive steps. These steps,
shown in Figure 1 for a virus that enters via endocytosis
and moves to the nucleus (e.g., an adeno- or polyomavi-
rus), start with events at the cell surface and end with
the decondensation of the genome at the site of replica-
tion. As the virus progresses in its entry program, it un-
dergoes changes that lead to events such as penetration,
capsid destabilization, and uncoating of the genome.
Many of these changes result from conformational alter-
ations in metastable viral structures. They are triggered
by receptor binding, exposure to low pH, reentry into a re-
ducing environment, enzyme-induced covalent modifica-
tions, and other cellular cues (Earp et al., 2005; Harrison,
2005; Hogle, 2002; Smith and Helenius, 2004). Viruses
exploit such signals not only to induce changes in the par-
ticle and dissociation of protein subunits but also to coor-
dinate movement from one compartment and location in
the cell to another, ensuring that each step in the uncoat-
ing program occurs at the right point in the sequence, at
the right time, and in the right place.
Although the incoming viruses depend on cues from the
cell, the cell also responds to signals induced by the virus.
Simply by binding to surface receptors, and perhaps by
clustering them, many viruses ‘‘knock at the door’’ of the
cell by activating cellular signaling cascades. This is often
essential because it results in the local activation of ligand-
triggered processes that viruses require for entry, such as
caveolar/raft endocytosis, clathrin-coat assembly, and
actin-cortex dissociation. This aspect of virus entry is
complex but increasingly central for understanding the in-
fection process.
Virus Receptors
In order to infect, viruses must first bind to the cell surface.
The surface structures that they bind to are of two general
types depending on the functional consequences of the
interaction. Attachment factors serve to bind the particles
and thus help to concentrate viruses on the cell surface.
Such interactions can be relatively nonspecific. Often
they involve interactions with heparan sulfate or other car-
bohydrate structures on the cell surface (Ugolini et al.,
1999; Vlasak et al., 2005; Young, 2001).
Unlike attachment factors, virus receptors actively pro-
mote entry. They can do so by initiating conformational
changes in the virus particle, by activating signaling path-
ways, and by promoting endocytic internalization. Often
the receptors accompany the virus into the cell during en-
docytic uptake and may then play a role intracellularly in
the penetration reaction.730 Cell 124, 729–740, February 24, 2006 ª2006 Elsevier Inc.Given that the interactions are usually highly specific,
the presence of receptors determines to a large degree
which cell types and species can be infected. These inter-
actions and the molecules involved are of crucial impor-
tance for understanding not only the mechanisms of entry
but also the biology of infection and pathogenesis. In
Figure 1. Steps in the Endocytic Entry Program of a Typical
Animal Virus
Whether enveloped or nonenveloped, many viruses depend on the
host cell’s endocytic pathways for entry. They follow a multistep entry
and uncoating program that allows them to move from the cell periph-
ery to the perinuclear space. In this example, the virus proceeds to
deliver its uncoated genome into the nucleoplasm. The interaction be-
tween the virus and the host cell starts with virus binding to attachment
factors and receptors on the cell surface, followed by lateral movement
of the virus-receptor complexes and the induction of signals that result
in the endocytic internalization of the virus particle. After vesicular traf-
ficking and delivery into the lumen of endosomes, caveosomes, or the
ER, a change in the virus conformation is induced by cellular cues. This
alteration results in the penetration of the virus or its capsids through
the vacuole membrane into the cytosolic compartment. Enveloped
viruses use membrane fusion for penetration, whereas nonenveloped
viruses induce lysis or pore formation. After targeting and transport
along microtubules, the virus or the capsid binds, as in this example,
to the nuclear pore complex, undergoes a final conversion, and re-
leases the viral genome into the nucleus. The details in the entry pro-
gram vary for different viruses and cell types, but many of the key steps
shown here are general.
recent years, hundreds of attachment factors and recep-
tors for different viruses have been identified, resulting in
a large body of valuable information (Young, 2001). The
crystal structures of several viruses and viral proteins
bound to receptors have also been solved (Kwong et al.,
1998; Rossmann et al., 2002; Skehel and Wiley, 2000;
Stewart et al., 2003). Within the scope of this review, it is
not possible to discuss the attachment factors and recep-
tors in depth; however, it is important to emphasize that
the list encompasses a wide variety of different proteins,
lipids, and carbohydrates. Included are ion transporters,
adhesion factors, signaling proteins, and a variety of other
cell-surface receptors. Proteoglycans and glycolipids are
commonly used as virus receptors or attachment factors
(Young, 2001). Moreover, influenza viruses and some
paramyxoviruses have spike glycoproteins with lectin do-
mains that bind to sialic acid, and the major coat protein of
polyomaviruses, VP1, binds to the glycan moiety of spe-
cific gangliosides (Skehel and Wiley, 2000; Stehle and
Harrison, 1997; Tsai et al., 2003).
Although individual interactions between viruses and
their receptors are specific, they are often of low affinity.
However, the avidity increase resulting from multiple re-
ceptor binding sites on virus particles often guarantees
nearly irreversible binding. Moreover, multisite binding is
likely to cluster receptor proteins, which in turn may acti-
vate signaling pathways and/or recruitment to endocytic
structures (see below).
Numerous viruses are known to use more than one type
of receptor, either in parallel or in series. The consecutive
use of CD4 and a chemokine receptor by the human im-
munodeficiency virus (HIV type 1) is a well-studied exam-
ple of the latter. In this case, the two receptors are needed
to induce major conformational changes in the HIV enve-
lope protein that initiate membrane fusion (Berger et al.,
1999). Interestingly, HIV-1 can also bind to glycosylcera-
mides and heparan sulfate, interactions that may facilitate
the initial recruitment of virus to susceptible cells (Long
et al., 1994; Ugolini et al., 1999). Moreover, the presence
of specific glycosphingolipids in the target cell membrane
can enhance CD4/coreceptor-dependent fusion (Puri
et al., 1998). Viruses, in particular those that undergo rapid
mutation, are also known to be able to switch receptors
(Byrnes and Griffin, 2000; Klimstra et al., 1998) or adapt
to use alternative receptors when the primary receptor is
absent (Vlasak et al., 2005). This is one of the risks posed
by the current avian influenza epidemic: the avian hemag-
glutinin glycoprotein may, through mutations, evolve to in-
teract more potently with glycoconjugates on human cells.
The entry of coxsackie B virus provides an interesting
example of how viruses can exploit the different properties
of cell-surface receptors to bring about stepwise entry. In
this case, the host cells are epithelial cells that grow in
tight monolayers. Coxsackie B viruses are human picor-
naviruses that cause meningitis and myocarditis. They
are simple, nonenveloped RNA viruses that replicate in
the cytosol and do not need low pH for penetration.
They share an essential receptor molecule with adenovi-ruses, a glycoprotein called CAR (the coxsackie and ade-
novirus receptor) (Zhang and Bergelson, 2005). In epithe-
lial cells, CAR is a component of tight junctions and is
therefore not accessible to incoming viruses from the api-
cal side. A recent study addressed the question of how the
virus gains access to its receptor, i.e., how it breaches the
epithelial barrier (Coyne and Bergelson, 2006).
The starting point for the study was the observation that
many coxsackie B strains interact with a coreceptor pres-
ent on the apical surface of epithelial cells, the decay-
accelerating factor (DAF, a GPI-anchored protein) (Shieh
and Bergelson, 2002). Virus binding leads to crosslinking
of DAF molecules, inclusion into lipid rafts, and activation
of the tyrosine kinase c-Abl (Coyne and Bergelson, 2006).
Once activated, c-Abl was found to activate the Rho-
family small GTPase Rac, which in turn induced a reorga-
nization of the actin cytoskeleton and promoted transfer of
bound viruses from the apical surface to the tight-junction
region of the cell. This made it possible for the virus to as-
sociate with CAR and for CAR to induce a conformational
change in the virus particle, an obligatory step in picorna-
virus uncoating and entry (Hogle, 2002). To release its
RNA into the cytoplasm, the modified particles were
then internalized by caveolar endocytosis activated by
phosphorylation of Tyr14 in caveolin-1 by Fyn, a member
of the Src family of nonreceptor tyrosine kinases. The de-
tailed route taken by the virus inside the cell remains un-
clear at this point, but the final release of the viral RNA
into the cytosol is likely to occur in the endoplasmic retic-
ulum (ER).
This study elegantly demonstrates how a virus exploits
multiple cellular receptors and functions to overcome the
obstacles it encounters during entry into cells. In this
particular cellular context, the coreceptor is needed to
overcome the inaccessibility of the main receptor. As dis-
cussed below, the signaling cascades are often important
in both entry steps and downstream activation of the cyto-
skeleton and endocytic machinery.
Virus-Induced Signaling
It is apparent that many viruses make use of the cell’s sig-
naling pathways during entry. This was first recognized for
adenoviruses, which use CAR as a primary receptor and
integrins as coreceptors (Li et al., 1998; Nemerow and
Stewart, 1999). Nemerow and coworkers demonstrated
that the interaction between adenovirus pentons (protein
complexes which together with the hexons make up the
adenovirus capsid) and integrins activates phosphatidyl-
inositol 3-kinase (PI(3)K), which in turn activates Rac
and Cdc42, resulting in the polymerization of actin- and
clathrin-mediated endocytosis of the virus. Activation of
many different signaling pathways has since been de-
scribed with the involvement of a variety of factors, includ-
ing serine/threonine, tyrosine, and PI kinases; phospha-
tases; and a variety of small GTPases (including Arf,
Rab, and Rho family members) (Greber, 2002; Pelkmans
et al., 2005).Cell 124, 729–740, February 24, 2006 ª2006 Elsevier Inc. 731
Viruses use signaling activities to induce changes in the
cell that promote viral entry and early cytoplasmic events,
as well as to optimize later processes in the replication cy-
cle. Initially, the viruses need to make their presence on
the cell surface known so that the cell can launch an endo-
cytic response to bring them in. For example, the internal-
ization of SV40 by caveolar/raft endocytosis is regulated
by at least five different kinases (Pelkmans et al., 2005). In-
hibition of tyrosine kinases in particular blocks internaliza-
tion and dramatically reduces infection (Chen and Norkin,
1999; Pelkmans et al., 2002). In other cases, a virus may
need to induce lateral movement along the membrane.
This can be seen very dramatically when viruses such as
murine leukemia virus and HIV-1 bind to filopodia and pro-
ceed to ‘‘surf’’ on the outside of these structures toward
the cell body (Lehmann et al., 2005). As discussed above,
lateral movement is also needed for coxsackie B viruses to
reach the CAR receptor in epithelial cells, and this move-
ment requires activation of c-Abl following virus-induced
crosslinking of DAF (Coyne and Bergelson, 2006).
The signals can be generated in several ways. The vi-
ruses may activate cellular signaling molecules directly
by using them as receptors. This may be why so many vi-
ruses bind integrins. Viruses may also induce signaling by
clustering specific cell-surface proteins or lipids. Interest-
ingly, a number of viruses use GPI-anchored proteins and
gangliosides, which are only associated with the outer
leaflet of the plasma membrane, as their receptors. That
this often leads to activation of tyrosine kinases on the
cytosolic side may be related to the fact that the GPI-
anchored proteins and gangliosides become lipid-raft
associated when clustered (Coyne and Bergelson, 2006;
Parton, 1994; Parton and Richards, 2003; Pelkmans
et al., 2002; Sharma et al., 2004). Being dually acylated,
some Src-family kinases (though not Src itself) are also en-
riched in lipid-raft microdomains, but on the cytoplasmic
surface of the membrane. Accordingly, there is increasing
evidence that many viruses associate with lipid rafts to ini-
tiate intracellular signaling (Coyne and Bergelson, 2006;
Damm et al., 2005; Ono and Freed, 2005).
Virus Penetration: The Cell Surface versus
Intracellular Membranes
The transfer of the genome and accessory proteins
through the barrier of a cellular membrane into the cytosol
is called penetration. For enveloped viruses, penetration
involves membrane fusion, and, for nonenveloped viruses,
it involves pore formation or membrane lysis. The molec-
ular mechanisms of viral membrane fusion are beginning
to be understood in increasingly fine detail but will not
be considered here (Earp et al., 2005; Harrison, 2005; Kie-
lian and Rey, 2006). For the most part, the penetration
mechanisms of nonenveloped viruses are less well under-
stood. However, recent single-particle cryo-EM analysis
of polioviruses bound to receptor-containing membranes
has started to provide detailed information on the struc-
tural changes involved in picornavirus penetration and
the organization of poliovirus-induced membrane pores732 Cell 124, 729–740, February 24, 2006 ª2006 Elsevier Inc.through which the viral RNA is believed to enter the cyto-
plasm (Bubeck et al., 2005).
The cellular membrane penetrated during virus entry is
either the plasma membrane or the limiting membrane of
an intracellular organelle, the lumen of which viruses reach
after endocytosis. In all known cases, the viruses or their
capsids penetrate first into the cytosol. Most RNA viruses
(though not all) replicate in the cytosol, often in contact
with specific organelles (Salonen et al., 2005). With the ex-
ception of poxviruses and iridoviruses, DNA viruses and
their capsids are subsequently transported to the nucleus
for replication.
It has been known for a long time that certain enveloped
viruses such as herpes simplex virus 1 (HSV-1); Sendai
virus; and many retroviruses, including HIV, have pH-inde-
pendent fusion proteins and can therefore penetrate into
cells by fusing directly with the plasma membrane. It is
generally assumed that fusion events at the plasma mem-
brane lead to productive infection, although this is difficult
to prove because virus particles are also continuously
endocytosed. Among nonenveloped viruses, several fam-
ilies, including some picornaviruses (such as polio) and
polyomaviruses, do not require low pH for penetration.
While many of these are known to require endocytosis
for penetration, it has been argued that some may pene-
trate directly through the plasma membrane, though this
remains contentious (Hogle, 2002).
However, if we view the whole spectrum of viruses, the
majority do need endocytic internalization for penetration
and productive infection, most likely because endocytosis
offers real advantages. Viruses that are ferried into cells
inside endocytic vesicles can move deep into the cyto-
plasm, bypassing many of the barriers associated with
the membrane cortex and cytosolic crowding (Marsh
and Bron, 1997) and exploiting the molecular motors
that are normally recruited to endocytic vesicles (Dohner
and Sodeik, 2005). A dependence on low pH for penetra-
tion allows viruses to use the decreasing pH of endocytic
organelles as a cue to activate the penetration reactions
and allows viral escape to the cytoplasm at specific loca-
tions or before the virus is delivered to the hydrolytic lyso-
somes (Helenius et al., 1980). In addition, no viral compo-
nents remain on the cell surface after penetration for
detection by the host’s immune defenses.
Virus Penetration through
Clathrin-Mediated Endocytosis
Of the endocytic pathways taken by viruses, the most
commonly used is the clathrin-mediated endocytic route
(Figure 2C and Figures 3A and 3B). It transports incoming
viruses together with their receptors into early and late en-
dosomes. Clathrin-mediated endocytosis is a continuous
process, and, for virus entry, it is usually rapid and efficient
(Marsh and Helenius, 1989). The incoming viruses are
often exposed to the acidic milieu of endosomes within
minutes after internalization, and many respond to the
pH drop by undergoing changes that lead to penetration.
Depending on the pH threshold, the site of penetration is
Figure 2. Endocytic Pathways Used by Viruses
In mammalian cells, many different mechanisms are available for the endocytic internalization of virus particles. Some of these mechanisms, such as
clathrin-mediated endocytosis, are ongoing, whereas others, such as caveolae, are ligand and cargo induced. Currently, there is evidence for six
pathways.
(A) Macropinocytosis is involved in the entry of adenoviruses.
(B) A clathrin-independent pathway from the plasma membrane has been shown to exist for influenza virus and arenaviruses.
(C) The clathrin-mediated pathway is the most commonly observed uptake pathway for viruses. The viruses are transported via early endosomes to
late endosomes and eventually to lysosomes.
(D) The caveolar pathway is one of several closely related, cholesterol-dependent pathways that bring viruses including SV40, coxsackie B, mouse
polyoma, and Echo 1 to caveosomes, from which many of them continue, by a second vesicle transport step, to the ER.
(E) A cholesterol-dependent endocytic pathway devoid of clathrin and caveolin-1, used by polyomavirus and SV40.
(F) A pathway similar to (D) except dependent on dynamin-2. It is used by Echo virus 1.
Depending on the virus and cell type, penetration reactions occur in five locations: the plasma membrane, early and late endosomes, caveosomes,
and the ER. Note that the additional endocytic mechanism of phagocytosis also operates in many cells but has not as yet been linked to virus entry
and is not included here.either the early (pH 6.5 to 6.0) or the late endosome (pH 6.0
to 5.5). In some cases, such as for Ebola virus, SARS co-
ronavirus, and the nonenveloped mammalian reoviruses,
acidic pH alone is not sufficient to induce fusion, and pro-
teolytic cleavages in viral proteins by acid-dependent en-
dosomal proteases, in particular cathepsins L and B, are
needed to trigger the change to the penetration-compe-
tent state (Chandran et al., 2005; Ebert et al., 2002; Sim-
mons et al., 2005). For avian leukosis virus, both interac-
tion of the viral envelope protein with a specific receptor
(Damico et al., 1998; Hernandez et al., 1997) and low pH
(Mothes et al., 2000) are required for fusion.
Single-particle tracking of influenza virus in cultured
simian kidney epithelial cells shows that, although
60% of the particles enter via clathrin-coated pits, 40%
use a clathrin-independent pathway (Rust et al., 2004)
(Figure 2B). Surprisingly, of those that use the clathrin-
dependent pathway, only 5% associate with preexistingclathrin-coated domains in the membrane; the majority
enter via coated pits that assemble underneath the sur-
face bound viral particles. This implies induction of trans-
membrane signaling by the receptor bound virus particles.
A similar induction of coated-pit formation has also been
observed for reovirus and Semliki Forest virus (SFV)
(Ehrlich et al., 2004; A. Vonderheit and A.H., unpublished
data); whether this represents recruitment of clathrin-
coat components to the clustered cytoplasmic domains
of viral receptor proteins or a more complex signaling cas-
cade leading to clathrin recruitment is unclear.
Endocytic clathrin-coated vesicles deliver their con-
tents to early endosomes (Figure 2C). These organelles,
though morphologically complex, have usually been con-
sidered to be a homogeneous population. However, there
is increasing evidence that viruses and other endocytosed
cargo are selectively targeted to specific populations of
endosomes (Kirkham et al., 2005). For example, the earlyCell 124, 729–740, February 24, 2006 ª2006 Elsevier Inc. 733
Figure 3. Electron Micrographs Showing
Virus Internalization by Clathrin- or Cav-
eolar/Raft-Mediated Endocytosis
(A and B) Semliki Forest virus, a 70 nm diameter
enveloped alphavirus, is internalized by cla-
thrin-coated pits (A) and vesicles (B) for endo-
cytosis and infection. Here, the virus is interact-
ing with a BHK-21 cell.
(C and D) Simian virus 40, a small 50 nm diam-
eter nonenveloped DNA virus, binds to gangli-
osides in the plasma membrane of CV-1 cells
and enters via caveolae (C) and tight-fitting
small vesicles. The viruses are transported
through caveosomes to the ER, where many
accumulate in smooth membrane domains
(D). Scale bar in (A) and (C) = 100 nm, (B) = 200
nm, and (D) = 250 nm. (A), (C), and (D) are
courtesy of J. Kartenbeck and A.H. (B) is repro-
duced from Helenius et al. (1980), The Journal
of Cell Biology, 1980, volume 84, pp. 404–420
by copyright permission of The Rockefeller
University Press.endosomes that receive the incoming influenza viruses
belong to a population that rapidly relocates the viruses,
by microtubule-mediated transport, to the perinuclear re-
gion, where penetration occurs by fusion (Lakadamyali
et al., 2003). SFV fuses soon after delivery to Rab5 and
EEA1-positive early endosomes, but the fused virus is then
transported in Rab7-positive carriers to late endosomes
(Vonderheit and Helenius, 2005). There is also a recent
observation that vesicular stomatitis virus (VSV) may
fuse with the internal membrane vesicles of multivesicular
endosomes and that these internal membranes subse-
quently fuse with the limiting membrane of late endosomes
to release the viral RNA to the cytoplasm (Le Blanc et al.,
2005). In this case, penetration would involve two mem-
brane fusion events, the first mediated by the viral enve-
lope protein and the second by an as yet uncharacterized
cellular mechanism. Interestingly, the endocytic uptake and
penetration of anthrax toxin also appears to involve a two-
step process, the first involving interaction of the toxin with
the internal membranes of a multivesicular endosome and
the second a back fusion of these membranes with the
endosome-limiting membrane (Abrami et al., 2004).
The complexity of the clathrin-mediated endocytic
pathway is illustrated by the increasing number of alterna-
tive cofactors, adaptors, and tethering proteins that are in-
volved in the formation of clathrin-coated pits and vesicles
(Robinson, 2004). Using small interfering RNA (siRNA) si-
lencing screens, more than 90 different kinases have re-
cently been shown to regulate the clathrin-mediated inter-
nalization and early steps of infection of HeLa cells by VSV
(Pelkmans et al., 2005). These kinases belong to many dif-
ferent classes, including regulators of the cytoskeleton,
cell cycle, cell growth, and membrane trafficking. They ei-
ther increase or decrease the efficiency of VSV entry and
early steps in the infection cycle. Many of the kinases734 Cell 124, 729–740, February 24, 2006 ª2006 Elsevier Inc.were shown to have a direct effect on the clathrin-medi-
ated endocytosis of other ligands.
Virus Penetration Following
Clathrin-Independent Endocytosis
That some viruses use clathrin-independent pathways for
endocytosis and infection is now widely accepted. The
best studied of these are the caveolar/raft pathways first
observed for SV40, a simple nonenveloped DNA virus (An-
derson et al., 1996; Kartenbeck et al., 1989; Stang et al.,
1997). The caveolar/raft pathways, of which there are at
least three related variants (Figures 2D–2F), seem to spe-
cialize in the internalization of lipids including cholesterol,
GPI-anchored proteins, and components of cholesterol-
rich microdomains (lipid rafts). Caveolae are also involved
in the transcytosis of serum components in endothelial
cells, and many cargo molecules of these pathways
seem to have a role in signaling.
The capsids of SV40 and the related polyomavirus are
composed of 72 homopentameric VP1 protein units that
resemble cholera toxin B chain pentamers (Stehle et al.,
1996; Stehle and Harrison, 1997). Like cholera toxin, these
viruses bind to the sugar moiety of gangliosides and enter
cells via caveolar/raft pathways that are dependent on
cholesterol (Figures 2D and 2E) and the activation of tyro-
sine-kinase signaling cascades (Anderson et al., 1996;
Pelkmans et al., 2001; Smith et al., 2003a; Stang et al.,
1997; Tsai et al., 2003). Activation involves tyrosine
kinases, PI kinases, and raft lipids. Dynamin 2, actin, cav-
eolin-1, and Rho GTPases are also involved, depending
on the virus and the cell type (Pelkmans et al., 2002). Inter-
nalization occurs via caveolae that are activated for long-
distance transport in the cytosol or via small vesicles that
lack caveolin-1 (Damm et al., 2005; Tagawa et al., 2005)
(Figures 3C and 3D).
The caveolar/raft pathway takes the majority of internal-
ized viruses first to pH-neutral organelles in the cytoplasm
called caveosomes (Figure 2D). Following a second acti-
vation step, the virions are then transported by caveolin-
free, microtubule-dependent vesicles trafficking to the
ER, where penetration occurs (Pelkmans et al., 2001). A
recent study suggests that a lumenal ER protein, ERp29,
a thioredoxin homolog without thiol oxidoreductase activ-
ity, facilitates penetration of polyomavirus by exposing the
hydrophobic, C-terminal arm of VP1 (Magnuson et al.,
2005). In the case of SV40, we have found that the redox
conditions in the ER, as well as two thiol oxidoreductases,
PDI and ERp57, are important for SV40 uncoating and
infection (M. Schelhaas, L. Pelkmans, and A.H., unpub-
lished data). Since siRNA silencing of derlin 1, a protein
linked to the reverse translocation of substrates for ER-as-
sociated protein degradation (ERAD), inhibits infection, it
is likely that components of the ERAD pathway play a cen-
tral role in SV40 penetration from the ER. Interestingly,
a similar mechanism may explain how the cholera toxin
A chains penetrate into the cytosol (Tsai et al., 2002).
RNAi silencing screens with the entire human kinome
have demonstrated that, in HeLa cells, the caveolar/raft
pathways that mediate SV40 entry depend on some 80
different kinases. The set of kinases show only partial
overlap with those that regulate the clathrin-mediated en-
try of VSV (Pelkmans et al., 2005). Interestingly, many of
the kinases involved in SV40 entry are known to have func-
tions in integrin signaling and actin regulation.
Other viruses that use caveolar/raft endocytosis include
Echo 1, a picornavirus that binds to integrins, and cox-
sackie B in human Caco-2 epithelial cells (Coyne and Ber-
gelson, 2006; Pietiainen et al., 2005). For Echo 1 virus,
caveolar/raft uptake and entry require signaling that in-
volves protein kinase C, and penetration seems to occur
in caveosomes without the involvement of the ER (Pietiai-
nen et al., 2004; Upla et al., 2004).
In addition to these pathways, there is increasing evi-
dence for clathrin-independent pathways of virus entry
into the endosomal system (Figure 2B). Such a pathway
has been observed for the arenavirus lymphocytic chorio-
meningitis virus (LCMV) and, as already mentioned, for
a fraction of incoming influenza viruses (Borrow and Old-
stone, 1994; Rust et al., 2004; Sieczkarski and Whittaker,
2002). The molecular mechanisms involved in the pathway
(or pathways) are not understood. By contrast, following
binding to CAR and av integrin coreceptors, adenovirus
type 2 (Ad2) activates an actin-dependent process clas-
sified as macropinocytosis (Figure 2A), but virus endo-
cytosis occurs via clathrin-coated pits. Inhibition of
macropinocytosis inhibits virus entry, but how exactly
this endocytic process influences virus penetration is un-
clear (Meier et al., 2002). Although the formation of primary
vesicles displays great heterogeneity, the subsequent
steps inside the cell involve either endosomes or caveo-
somes and require cholesterol (Imelli et al., 2004). That
these two organelle classes are not entirely independent
of each other is shown by their regulation through a smallCsubset of common kinases and by the observation that
cargo can be transferred between them (Pelkmans et al.,
2004).
Together with bacterial toxins such as cholera, anthrax,
and Shiga toxin, viruses are emerging as valuable ligands
for charting the various ligand-inducible pathways of en-
docytosis. The spectrum of pathways is often redundant
and cell-type specific. Differences in sensitivity to inhibi-
tors, expression of dominant-negative mutants, and live-
cell microscopy show that the pathways differ in their ki-
netics and their dependence on host-cell kinases; dyna-
mins; Rac-, Rab-, and Arf-family GTPases; actin and tubu-
lin; and cholesterol. The pathways are also likely to be
physiologically regulated (e.g., the upregulation of com-
pensatory pathways when clathrin-mediated endocytosis
is inhibited; Damke et al., 1995). This may be one reason
why viruses such as SV40 and influenza can use several
different pathways, enabling them to infect a wide range
of cells under various conditions. The question arises as
to whether the pathways that have been identified in tissue
culture systems, in some cases under unusual experimen-
tal conditions, occur in the relevant cells in vivo or whether
there are additional endocytic entry mechanisms still to be
discovered.
It will take some effort to define how many different en-
docytic pathways operate in cells and their normal func-
tional activities. Further analysis using siRNA screens,
with larger siRNA libraries and other viruses, may allow
the identification of unique sets of proteins that are re-
quired for the entry of viruses that use a specific endocytic
mechanism, thus providing a genetic fingerprint for each
pathway. Such analyses should demonstrate whether
these different pathways involve distinct molecular mech-
anisms or whether overlapping sets of proteins mediate
several variants of essentially a single endocytic mecha-
nism.
Virus Transmission: Cell-free versus
Cell-Cell Infection
The existence of pH-independent fusion proteins has an
important consequence for some viruses. When these
proteins are expressed on the cell surface, they can allow
fusion of the infected cell with neighboring noninfected
cells expressing appropriate receptors. This leads to for-
mation of heterokaryons, or syncytia, and potentially al-
lows for the dissemination of the virus without the forma-
tion of mature virus particles. Nevertheless, in the
majority of cases, the transfer of viral genomes from cell
to cell appears to occur through the formation of virus par-
ticles that are released from infected cells and use the
mechanisms described above to enter new uninfected
hosts. Interestingly, the herpes virus varicella-zoster
(VZV) appears to use cell-free viruses to spread from hu-
man to human but direct cell-to-cell transfer, without for-
mation of infectious virions, to spread within an infected
host (Chen et al., 2004). Most studies of viral entry are,
by necessity, conducted in tissue culture systems using
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targets for infection in vivo. Although these systems have
contributed greatly to our understanding of virus entry,
they do not fully replicate the in vivo scenario, and, as
a consequence, crucial aspects of entry mechanisms
may be missed.
In experimental systems, the entry stage of infection is
usually studied by adding cell-free virus particles to cells.
Often the efficiency of entry is low, and experimenters fre-
quently enhance virus adsorption by including charged
polymers, such as polybrene, in the medium or by gently
centrifuging virus particles onto cells (O’Doherty et al.,
2000). Viruses that have adapted to growing in tissue cul-
ture cells can show an enhanced tendency to use proteo-
glycans for initial recruitment to cell surfaces (de Haan
et al., 2005; Vlasak et al., 2005). Indeed, HIV-1 strains
adapted to grow in T cell lines appear to bind to cells via
proteoglycans before engaging CD4 and coreceptors
(Ugolini et al., 1999). Together this suggests that the
events involved in virus adsorption and entry in tissue cul-
ture may be different from those that occur in vivo. A num-
ber of recent studies suggest why this is the case.
Transmission of viruses from cell to cell in epithelial
cells, for example, may occur through the basolateral do-
mains, where a virus released from one cell can be effec-
tively deposited on adjacent cells, minimizing the events
associated with virus recruitment to the cell surface. Vac-
cinia virus (VV) provides an extreme example. VV is pro-
duced in several forms, of which the intracellular mature
virus (IMV) and extracellular enveloped virus (EEV) are ca-
pable of infecting target cells. The EEV is initially assem-
bled with three membranes and is released to the cell sur-
face when the outer membrane fuses with the plasma
membrane to produce an extracellular double-mem-
braned particle. The EEV remains bound to the surface
of the producer cell and induces the polymerization of cy-
toplasmic actin comets that push the virus around on the
surface of the cell, often at the tips of filopodium-like pro-
jections (Smith et al., 2003b; Wolffe et al., 1998) (see Fig-
ure 4 and Greber and Way, 2006 [this issue of Cell]). In
confluent cultures, and presumably in vivo as well, these
projections push viruses into neighboring cells and en-
hance cell-to-cell transfer. Deletion of viral proteins in-
volved in transmembrane signaling and actin nucleation
reduces the viral plaque size in tissue culture and patho-
genesis in vivo (Smith et al., 2003b; Wolffe et al., 1998).
Recently, structures termed infectious or virological
synapses have been increasingly implicated in cell-to-
cell virus transfer. Initially described for the transfer of
the human T cell leukemia virus type 1 (HTLV-1) from in-
fected to uninfected T cells, these areas of intimate con-
tact between the infected and uninfected cells were rec-
ognized to have features in common with immunological
synapses (Igakura et al., 2003). In contrast to T cell killing
or antigen presentation, virological-synapse formation be-
tween T cells does not require major histocompatibility an-
tigens (Jolly and Sattentau, 2004). The synapse provides
a domain where virus assembly can be focused to release
particles efficiently to a target cell. Similar means of trans-736 Cell 124, 729–740, February 24, 2006 ª2006 Elsevier Inc.fer have been described for herpes viruses (Johnson and
Huber, 2002) and for the T cell to T cell transfer of HIV (Jolly
and Sattentau, 2004).
A particularly intriguing example of infectious synapse
function is that described for dendritic cells. For many
years it has been recognized that a highly efficient way
of infecting T cells with HIV in culture is to first present
the virus to dendritic cells (Cameron et al., 1992). HIV in-
fection of dendritic cells can occur but is generally re-
garded as being inefficient. Recent studies have sug-
gested an alternative mode of interaction whereby
viruses may be captured by C type lectins (Geijtenbeek
et al., 2000; Turville et al., 2002), and perhaps other recep-
tors involved in antigen acquisition, and internalized into
endocytic vesicles without infecting the dendritic cell.
This virus can be regurgitated when dendritic cells interact
with CD4-positive T cells and is able to infect the T cell in
trans through infectious or virological synapses—a pro-
cess that mimics the normal course of antigen presenta-
tion (McDonald et al., 2003). Viruses can be harbored in
endocytic vesicles for hours, if not days, without losing in-
fectivity, potentially allowing the dendritic cells in vivo to
undergo maturation and relocation from peripheral tissue,
Figure 4. Swine Pox Viruses at the Tip of Projections in the
Plasma Membrane of the Infected Cell
After release from the cell, the viruses remain associated with the
plasma membrane, where they induce assembly of actin filaments.
The projections that are formed are motile and push the viruses into
contact with neighboring cells. In this way, they promote infection
within tissues. Note the actin filaments emanating from the area of vi-
rus cell contact. Courtesy of J. Kartenbeck. Scale bar = 500 nm.
where they would initially encounter viruses, to lymphoid
organs. The endocytic compartment in which endocy-
tosed viruses are sequestered is morphologically complex
and bears some similarity to the compartments in macro-
phages where HIV assembles (Garcia et al., 2005). Al-
though trans-infection has been documented in tissue cul-
ture, it remains unclear whether it operates in the same
manner in vivo where, for HIV at least, infection of dendritic
cells and the production of viruses in infected dendritic
cells may be more relevant (Turville et al., 2004). Regard-
less, the transfer of viruses through infectious synapses is
likely to operate in both scenarios.
Similar dendritic-cell-mediated trans-infection routes
have been proposed for a number of other viruses, includ-
ing herpes, filo-, and flaviviruses (van Kooyk and Geijten-
beek, 2003). Thus, these viruses have adapted to exploit
a loophole in the defense strategies ranged against them
by effectively using the cell’s endocytosis and/or secre-
tory mechanisms to allow their release to be temporally
and spatially coordinated to focus infectious viruses on
target cells. It is likely that similar strategies are used in
various situations by different viruses; in particular, follow-
ing reactivation of latent viruses, the transfer of HSV and
varicella-zoster virus (chicken pox) from infected neuro-
nes to epithelial cells is likely to exploit specialized cell
junctions (Johnson and Huber, 2002).
Thus, although the full life cycle of a virus requires as-
sembly, dissemination by release from cells, and entry
into new targets, the time during which viruses are genu-
inely cell free may be minimal. These mechanisms may
limit the extent to which a virus is exposed to the humoral
immune system (Johnson and Huber, 2002) and may also
explain, for example, why, in HIV patients, infected T cells
harbor multiple proviral genomes, suggestive of cells hav-
ing undergone multiple, reasonably synchronous infection
events (Jung et al., 2002).
Viral Restriction
Many viruses only infect a restricted range of cells, limiting
their species tropism and cell tropism. Frequently, the re-
striction on infection is due to the absence of appropriate
receptors. With retroviruses, however, a number of other
mechanisms to limit viral replication have been discov-
ered, and many of these operate at the level of entry
(Towers and Goff, 2003). For HIV in particular, several
mechanisms have now been described through which vi-
rus replication can be limited independently of receptor
expression. Cellular RNA-editing enzymes can be pack-
aged into virus particles and can introduce mutations in
the viral genome during the reverse-transcription event
that occurs shortly after virus entry. HIV-1 uses its Vif pro-
tein to overcome this restriction by preventing packaging
of the editing enzymes into virus particles (Sheehy et al.,
2002). In another example, the so-called Lv1 (or Ref1) re-
striction that prevents HIV-1 replication in Old World mon-
keys is mediated by a homo-oligomeric protein called Trim
5a (Stremlau et al., 2004; Towers, 2005). Trim 5a appears
to bind to an exposed loop on the capsid protein thatCbecomes available when the capsid is released to the
cytoplasm after fusion (Ylinen et al., 2005). Trim 5a ap-
pears to prevent uncoating of the incoming particles by
crosslinking the capsid protein subunits, though in some
cases it may operate after reverse transcription (Ylinen
et al., 2005). The Fv1 restriction seen with murine leukemia
viruses operates after reverse transcription and prevents
nuclear entry (Towers et al., 2000). Interestingly, the Fv1
restriction maps to an endogenous retroviral gag gene
(Best et al., 1996), suggesting that interaction between in-
coming capsids and an endogenous Gag protein prevents
infection.
In another form of restriction, now termed Lv2, some
strains of HIV-1 and HIV-2 fail to replicate efficiently in
HeLa cells. The phenotype maps to specific amino acids
in both Env and capsids. For the Env-mediated restriction,
at least, the failure to efficiently infect cells appears to be
related to virus delivery to a raft-mediated endocytic path-
way, and experimental manipulations that disrupt raft-
mediated endocytosis overcome the restriction, as does
diverting the virus to a clathrin-mediated pathway by
pseudotyping the virus with the VSV-G protein (Marchant
et al., 2005; Schmitz et al., 2004). Thus, not only must vi-
ruses find their way to the correct pathway for infection,
but diversion to an alternative pathway, or blind alley,
can limit the potential for subsequent infection and repli-
cation. Other mechanisms through which the mode of
penetration determines the outcome of subsequent
events in virus entry appear to operate for other related
viruses (Kim et al., 2001).
Perspectives
Among the many challenges for the future is the need to
identify exactly how many endocytic mechanisms contrib-
ute to virus entry and to determine which viruses use these
pathways. RNAi screens similar to those described by
Pelkmans et al. (2005) will allow a systematic approach
to these questions with the possibility that specific routes
can be defined by the requirement for a unique set of
genes and their encoded proteins. Thus, each endocytic
mechanism might be given a unique genetic fingerprint.
Understanding these processes may allow specific cellu-
lar pathways or molecular machines to be targeted phar-
macologically to inhibit the entry of any virus that uses
the route for infection. Such an approach may offer the ad-
vantage that it will be more difficult for a virus to find a way
around the block by mutation. It will also be important to
show that the pathways identified in tissue culture exper-
iments operate in vivo during a normal infection. Such ex-
periments will be difficult, especially with human viruses,
but inhibitors identified through tissue culture experiments
may make it possible to address these issues.
At the level of cells and virus particles, developments in
morphological techniques from high-end light microscopy
to electron microscopy are allowing the events involved in
virus entry to be analyzed with increased spatial and
temporal resolution. Single-particle tracking of virus
particles containing components labeled with differentell 124, 729–740, February 24, 2006 ª2006 Elsevier Inc. 737
fluorochromes or fluorescent proteins is allowing specific
events to be followed in remarkable detail. For some vi-
ruses with high infectious-unit-to-particle ratios, such as
SFV, such studies provide direct information on entry.
More careful attention to the preparation and storage of
other viruses may allow similar morphological experi-
ments to be interpreted with the confidence that the
events observed represent the behavior of infectious par-
ticles. The ability to use microscopes in high-throughput
screens for inhibitors of virus entry or to determine key
components in the entry pathway will have a far-reaching
impact on our understanding of virus entry. Together,
these studies should provide detailed insights to the cellu-
lar mechanisms of endocytosis. The identification of natu-
ral ligands will also be key in establishing the biological rel-
evance of these pathways. If we revisit this topic in 5
years’ time, we will have a very much more detailed pic-
ture of virus entry. Viruses will continue to hold crucial
cards in our attempts to understand cells and their patho-
gens.
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